ASAP BioPharma Conference
Where Connection Powers Collaboration
November 17–19, 2025, Renaissance Boston Seaport District
November 17–19, 2025, Renaissance Boston Seaport District
Join the alliance leaders shaping the future of biopharma. From early discovery to commercialization, this is where strategic minds exchange insights, solve real-world challenges, and build the connections that drive science forward.
“The ASAP BioPharma Conference is unequivocally the most valuable event I attend each year. What sets it apart is its rich content. ASAP is where you go to learn from the best to elevate your career and alliance capabilities!”
Whether you’re a seasoned alliance professional or just starting out, you'll leave with actionable strategies and insights from real-world case studies specifically tailored to your experience level and organizational priorities.
Explore breakthrough topics reshaping alliance management, including AI and digital transformation, new alliance models, complex multi-partner ecosystems, and much more.
To help secure approval for your participation, we've prepared a customizable justification template highlighting the tangible ROI this conference offers to you and your organization.
“ASAP’s content is timely, relevant, and original. Others may try to duplicate the unique experience that ASAP has created, but none match the combination of cutting-edge programming, industry expertise, and dedicated community engagement.”
Conference Planning Committee
CO-CHAIR
Aida Bendt, CA-AM
Head of Alliance Management, Oncology R&D
AstraZeneca
CO-CHAIR
Chris Black, CA-AM
Head, Corporate Alliance Management & Integration
Merck
Jason Felsch, CSAP, CA-AM
Senior Director, Alliance Management
Acadia Pharmaceuticals
Katherine Kendrick, CSAP, CA-AM
Executive Director, Head of Alliance Management
Jazz Pharmaceuticals
Romuald Lainé, PhD, CSAP, CA-AM
Head of Evaluation & Partnering
Servier
Brooke Paige, CSAP, CA-AM
Global Alliance Management, Neuroscience, Rare Disease & Digital
Novartis Pharmaceuticals
Kristin Rosner, PhD, CSAP, CA-AM
Director of Alliance Management
Takeda Pharmaceuticals
Petra Sansom, PhD, CA-AM
Vice President, Alliance Management
Beam Therapeutics
Hélène Svahnqvist, CA-AM
Vice President, Head of Alliance Management
Life Edit
Cindy Yang, CSAP, CA-AM
Senior Director, Head of Alliance Management
Kezar Life Sciences
Arne Wörn, PhD
Global Head Alliance Management
Novartis Pharmaceuticals
"The ASAP BioPharma Conference is where the future of alliance management is shaped. The diverse range of topics and expert-led discussions provide a comprehensive understanding of the industry's direction. I leave every year feeling inspired and equipped to lead our alliances to new heights."
Speakers
Sarah Korman, PhD
General Counsel & Head of Business Operations
Isomorphic Labs
Jeremy Ahouse, PhD, CSAP, CA-AM
Vice President, Alliances
Flagship Pinoneering Medicines
Tressa Allington, PhD
Co-Founder & Senior Consultant
P3R Quality
Elnaz Atabakhsh, PhD
Director, Alliance Management
AstraZeneca
Aida Bendt, CA-AM
Head of Alliance Management, Oncology R&D
AstraZeneca
Karen Berna, CSAP, CA-AM
Senior Director
Jazz Pharmaceuticals
Tyson Bertmaring, CA-AM
Head of Stewardship
Dyno Therapeutics
Chris Black, CA-AM
Head, Corporate Alliance Management & Integration
Merck
Elodie Blanc, CSAP, CA-AM
Corporate Alliance Manager
Pierre Fabre
Tracy Blois, PhD
Head of Alliance Management, Executive Director BD
Amgen/p>
Nicole Boston, CAE, CA-AM
President & CEO
ASAP
Helena Cowley, CA-AM
Director, Global Alliance Management
Takeda
Christine David, CA-AM
Senior Director, Alliance Management
Merck
Dhruv Desai, CA-AM
Associate Director, Alliance Management
Takeda
Jacqueline Dim, CA-AM
Senior Director, Alliance Management
Kailera Therapeutics
Katherine Ellison, CA-AM
Head of Alliance Management
Illumina
Andrew Ferguson, PhD, CA-AM
Director, Global Oncology R&D Alliance Management
Takeda
Andi Gardner, PharmD, CA-AM
Senior Director, Alliance Management
Biogen
Erin Gibson
Director, Alliance Management & BD
Amgen
Samuel Gosselin, CA-AM
Alliance Executive
Lauren Griffey, CA-AM
Associate Director, Alliance Manager
Jazz Pharamceuticals
Nancy Griffin, EdD, CSAP, CA-AM
Vice President, Program & Alliance Management
Valo Health
Virginie Gruson, PhD, CA-AM
Head of Evaluation and Partnering
Servier
Maegan Harden, PhD, CA-AM
Associate Director, Alliances
Illumina
Nick Heath, PharmD
Associate Director, Center of External Innovation Alliance Operations
Takeda
Celine Hechard, PhD, CA-AM
Senior Director, Alliance Management
Merus
Christine Klatt, CSAP, CA-AM
Consultant
Carberry Consulting
Adam Kornetsky
Partner
Vantage Partners
Brian Lam
Director, Alliance Management
Novartis
Beatrice Lana, PhD, CA-AM
Strategic Alliance Executive
Cancer Research Horizon
Yaminah Leggett-Wells
Senior Director, Alliance Management
Amgen
Kevin Little, PhD, CSAP, CA-AM
Senior Alliance Director
Novo Nordisk
Nick Marchese
Senior Director, Alliance Management
Pfizer
Craig McDonald, CA-AM
Senior Director, Alliance Management
Chiesi Group
Lisa Mendoza, PhD, CSAP, CA-AM
Head of Partner Success
Dyno Therapeutics
Jill McGuinn, CA-AM
Executive Director, Corporate Alliance Management
Merck
Josh Miller, PhD
Director, Strategic Alliances
Merck
Sharon Morgenbesser, PhD, CA-AM
Director, Alliance Management for Genetic Medicines
Alloy Therapeutics
Carl Olson
Head of Alliance Management
Biogen
Claire Patterson
Senior Manager, Alliance Management
Amgen
Swati Prasad, PhD, CSAP, CA-AM
Alliance Executive
Liz Rayer, PhD
Partner
Vantage Partners
Louis Rinfret, PhD
Founder & CEO
alliancboard
Delira Robbins, PhD
Manager, Alliance Management/p>
Amgen
Kristin Rosner, PhD, CSAP, CA-AM
Director, R&D Global Alliance Mangement
Takeda
Brian Stewart, CA-AM
Executive Director, Head of Alliance Management
Daiichi Sankyo
Jan Twombly, CSAP, CA-AM
President
The Rhythm of Business
Cindy Warren
Chief Business Officer
Cue Biopharma
Doug Williams
Senior Director, Global Alliance Management
Incyte
Arne Wörn, PhD
Global Head of Alliance Management
Novartis
Cindy Yang, CSAP, CA-AM
Senior Director, Head of Alliance Management
Kezar Life Sciences
“ASAP’s BioPharma Conference remains the premier and largest community of professionals in alliance and partnership leadership. If you only can make it to one event this year…make it this one!”
Conference Program
Professional Development Credits
By attending the ASAP BioPharma Conference, you will earn 12 credit hours toward CA-AM and CSAP certification or renewal.
Registration
| Early Bird 15% Discount (by Oct 3) | Regular Rate | |
|---|---|---|
| Regular Rate Includes complimentary ASAP membership |
$2,299 |
$2,699 |
| Member Rate – 20% Discount |
$1,839 |
$2,159 |
Cancellation Policy
To view ASAP cancellation policy, click here
"The ASAP BioPharma Conference is a transformative experience that brings together the brightest minds in the industry. The insights and connections I gain here are invaluable for driving innovation and success in our alliances.”
Hotel & Travel
ASAP has negotiated a discounted rate of $229.00+ per night at the Renaissance Boston Seaport District. This rate is only available until the block is sold out or the cutoff date of Monday, October 27, 2025. To receive the discounted rate, you must book through the ASAP room block at https://book.passkey.com/go/ASAPBioPharmaConf2025.
"Attending the ASAP BioPharma Conference has been a game-changer for my career. The sessions are packed with actionable strategies and the networking opportunities are unparalleled. It's a must-attend event for anyone serious about alliance management."
Sponsors
Thank you to the following companies who have invested and are supporting the event. Without their generosity, this event would not be possible.
Interested in learning more about exhibiting or sponsoring? Contact us!
Platinum
Gold
Silver
Bronze
ASAP Community
Join the ongoing conversation and in-depth discussion happening in ASAP Connect, or follow us on LinkedIn and Facebook.
Future BioPharma Conferences
November 9–11, 2026
Renaissance Boston Seaport District
606 Congress Street
Boston, Massachusetts 02210
617-388-4111